Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

Prior treatment

• Subjects for which minimally invasive surgery is contraindicated as determined by the Investigator
• Subjects with comorbidities or medical characteristics, which would preclude the surgical procedure in the opinion of the Investigator
• Subjects diagnosed with a bleeding disorder and/or cannot be removed from their anticoagulants prior to surgery based on surgeon discretion and standard-of-care
• Female subjects pregnant at the time of the surgical procedure.
• Subjects who have participated in an investigational drug or device research study within 30 days of enrollment that would interfere with this study

Other illness

• Subjects with active infections including but not limited to pneumonia, urinary tract, cellulitis, or bacteremia

Other

• Non-oncology subjects with an estimated life expectancy of less than 6 months; oncology subjects considered for cystectomy with a life expectancy less than 24 months; oncology subjects considered for nephrectomy with a life expectancy less than 60 months; oncology subjects considered for prostatectomy with less than a 10-year life expectancy.
• Subjects who are considered to be part of a vulnerable population (e.g., prisoners or those without sufficient mental capacity)

• Adult subjects (age ≥ 22 years) as required by local law
• Subject has been indicated for a radical prostatectomy, radical cystectomy, or nephrectomy (partial or radical) surgical procedure
• Subject is an acceptable candidate for a fully robotic assisted surgical procedure, a laparoscopic surgical procedure, or an open surgical procedure
• The subject is willing to participate and consents to participate, as documented by a signed and dated informed consent form